• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病静脉注射免疫球蛋白抵抗的生物标志物与冠状动脉病变。

Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.

机构信息

Department of Cardiovascular Diseases, Children's Hospital, Zhejiang University School of Medicine, 3333 Binsheng Road, Hangzhou 310052, China.

出版信息

World J Pediatr. 2019 Apr;15(2):168-175. doi: 10.1007/s12519-019-00234-6. Epub 2019 Feb 27.

DOI:10.1007/s12519-019-00234-6
PMID:30809758
Abstract

BACKGROUND

Currently, there are no reliable indicators for predicting intravenous immunoglobulin resistance and coronary artery lesions in the early stage of Kawasaki disease.

METHODS

A total of 300 patients with Kawasaki disease were studied retrospectively. Laboratory data were compared between the intravenous immunoglobulin resistant (29 patients) and responsive groups, and between the groups with coronary artery lesions (48 patients) and without coronary artery lesions.

RESULTS

The intravenous immunoglobulin resistant group had significantly higher D-dimer, globulin, interleukin-6 and serum ferritin levels in comparison to the intravenous immunoglobulin responder group. D-dimer level had a sensitivity of 87.0% and a specificity of 56.3% for predicting intravenous immunoglobulin resistance at a cutoff point of 1.09 mg/L. Globulin had a sensitivity of 62.1% and a specificity of 82.3% for predicting intravenous immunoglobulin resistance at a cutoff point of 34.7 g/L. Serum ferritin level had a sensitivity of 42.9% and a specificity of 88.8% for predicting intravenous immunoglobulin resistance at a cutoff point of 269.7 ng/mL. The patients with coronary artery lesions had higher D-dimer and tumor necrosis factor-α level. D-dimer level had a sensitivity of 50% and a specificity of 78.6% for predicting coronary artery lesions at a cutoff point of 1.84 mg/L. Based on analysis by multivariate logistic regression, serum ferritin and globulin were independent risks for intravenous immunoglobulin resistance, D-dimer was independent risk for coronary artery lesions.

CONCLUSIONS

Elevated serum ferritin, globulin and D-dimer levels are significantly associated with intravenous immunoglobulin resistance in Kawasaki disease. Moreover, serum D-dimer is significantly increased in Kawasaki disease with coronary artery lesions.

摘要

背景

目前,尚无可靠指标来预测川崎病早期静脉注射免疫球蛋白(IVIG)抵抗和冠状动脉病变。

方法

回顾性研究了 300 例川崎病患者。比较 IVIG 抵抗(29 例)和 IVIG 反应组、有冠状动脉病变(48 例)和无冠状动脉病变组的实验室数据。

结果

IVIG 抵抗组的 D-二聚体、球蛋白、白细胞介素-6 和血清铁蛋白水平明显高于 IVIG 反应组。D-二聚体水平在截断值为 1.09mg/L 时预测 IVIG 抵抗的敏感性为 87.0%,特异性为 56.3%。球蛋白在截断值为 34.7g/L 时预测 IVIG 抵抗的敏感性为 62.1%,特异性为 82.3%。血清铁蛋白水平在截断值为 269.7ng/mL 时预测 IVIG 抵抗的敏感性为 42.9%,特异性为 88.8%。有冠状动脉病变的患者 D-二聚体和肿瘤坏死因子-α水平较高。D-二聚体水平在截断值为 1.84mg/L 时预测冠状动脉病变的敏感性为 50%,特异性为 78.6%。多因素 logistic 回归分析显示,血清铁蛋白和球蛋白是 IVIG 抵抗的独立危险因素,D-二聚体是冠状动脉病变的独立危险因素。

结论

血清铁蛋白、球蛋白和 D-二聚体水平升高与川崎病 IVIG 抵抗显著相关。此外,川崎病合并冠状动脉病变时血清 D-二聚体明显升高。

相似文献

1
Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.川崎病静脉注射免疫球蛋白抵抗的生物标志物与冠状动脉病变。
World J Pediatr. 2019 Apr;15(2):168-175. doi: 10.1007/s12519-019-00234-6. Epub 2019 Feb 27.
2
Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.川崎病中静脉注射免疫球蛋白抵抗及冠状动脉病变的预测因素
Pediatr Rheumatol Online J. 2017 Mar 21;15(1):17. doi: 10.1186/s12969-017-0149-1.
3
Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.D - 二聚体水平升高是静脉注射免疫球蛋白无反应性川崎病伴冠状动脉病变的一个危险因素。
Ther Apher Dial. 2015 Apr;19(2):171-7. doi: 10.1111/1744-9987.12235. Epub 2014 Sep 26.
4
Predictive value of red blood cell distribution width for coronary artery lesions in patients with Kawasaki disease.红细胞分布宽度对川崎病患者冠状动脉病变的预测价值。
Cardiol Young. 2016 Aug;26(6):1151-7. doi: 10.1017/S1047951115002140. Epub 2015 Oct 5.
5
Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.血清淀粉样蛋白 A 作为川崎病免疫球蛋白抵抗的生物标志物。
Ann Med. 2023;55(2):2264315. doi: 10.1080/07853890.2023.2264315. Epub 2023 Oct 23.
6
A machine learning approach to predict intravenous immunoglobulin resistance in Kawasaki disease patients: A study based on a Southeast China population.基于中国东南人群的机器学习方法预测川崎病患儿静脉注射免疫球蛋白抵抗:一项研究。
PLoS One. 2020 Aug 27;15(8):e0237321. doi: 10.1371/journal.pone.0237321. eCollection 2020.
7
Novel predictors of intravenous immunoglobulin resistance in Chinese children with Kawasaki disease.川崎病中国儿童静脉注射免疫球蛋白抵抗的新预测因子。
Pediatr Infect Dis J. 2013 Aug;32(8):e319-23. doi: 10.1097/INF.0b013e31828e887f.
8
Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.白细胞介素-6 易于成为预测川崎病不完全反应和免疫球蛋白静脉注射无反应的候选生物标志物,而非冠状动脉瘤。
Clin Exp Med. 2019 May;19(2):173-181. doi: 10.1007/s10238-018-00544-5. Epub 2019 Jan 8.
9
Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.血清脂质对川崎病静脉免疫球蛋白抵抗和冠状动脉病变的预测价值。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4210-e4220. doi: 10.1210/clinem/dgab230.
10
A new model for predicting intravenous immunoglobin-resistant Kawasaki disease in Chongqing: a retrospective study on 5277 patients.重庆预测静脉注射免疫球蛋白抵抗川崎病的新模型:5277 例患者的回顾性研究。
Sci Rep. 2019 Feb 11;9(1):1722. doi: 10.1038/s41598-019-39330-y.

引用本文的文献

1
Exploring ferroptosis-associated immune characteristics in Kawasaki disease through bioinformatics.通过生物信息学探索川崎病中与铁死亡相关的免疫特征。
Sci Rep. 2025 Aug 18;15(1):30261. doi: 10.1038/s41598-025-15182-7.
2
Immunophenotype of Kawasaki Disease: Insights into Pathogenesis and Treatment Response.川崎病的免疫表型:对发病机制和治疗反应的见解
Life (Basel). 2025 Jun 25;15(7):1012. doi: 10.3390/life15071012.
3
Prevalence of IVIG resistance in Kawasaki disease: a systematic review and meta-analysis.川崎病中静脉注射免疫球蛋白耐药的患病率:一项系统评价和荟萃分析。

本文引用的文献

1
A case of incomplete Kawasaki disease with extremely high serum ferritin and interleukin-18 levels.川崎病不完全型合并极高血清铁蛋白及白细胞介素-18 血症 1 例
BMC Pediatr. 2018 Dec 12;18(1):386. doi: 10.1186/s12887-018-1365-7.
2
Correlations of complication with coronary arterial lesion with VEGF, PLT, D-dimer and inflammatory factor in child patients with Kawasaki disease.川崎病患儿并发症与血管内皮生长因子、血小板、D-二聚体及炎症因子致冠状动脉病变的相关性。
Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5121-5126. doi: 10.26355/eurrev_201808_15706.
3
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.
Front Pediatr. 2025 Jul 4;13:1566590. doi: 10.3389/fped.2025.1566590. eCollection 2025.
4
Clinical value of combined detection of serum ferritin and N-terminal pro-brain natriuretic peptide in the assessment of Kawasaki disease in children over 1 year of age.血清铁蛋白与N末端脑钠肽前体联合检测在1岁以上儿童川崎病评估中的临床价值
Ital J Pediatr. 2025 Jul 15;51(1):229. doi: 10.1186/s13052-025-02076-7.
5
A visualized nomogram to predict intravenous immunoglobulin resistance in Kawasaki disease: a study based on the population in Southern China.预测川崎病静脉注射免疫球蛋白抵抗的可视化列线图:一项基于中国南方人群的研究
Ital J Pediatr. 2025 Apr 12;51(1):117. doi: 10.1186/s13052-025-01964-2.
6
Establishment and validation of a nomogram for coronary artery lesions in children with Kawasaki disease.川崎病患儿冠状动脉病变列线图的建立与验证
Front Cardiovasc Med. 2025 Jan 14;11:1522473. doi: 10.3389/fcvm.2024.1522473. eCollection 2024.
7
Effectiveness of Initial Corticosteroid Treatment in Kawasaki Disease Children Suspected to be IVIG Resistant.初始皮质类固醇治疗对疑似静脉注射免疫球蛋白无反应的川崎病患儿的有效性。
Pediatr Cardiol. 2024 Sep 24. doi: 10.1007/s00246-024-03657-9.
8
Predictive value of coagulation profiles for Kawasaki disease shock syndrome: a prospective cohort study.凝血指标对川崎病休克综合征的预测价值:一项前瞻性队列研究。
Front Pediatr. 2024 Aug 16;12:1450710. doi: 10.3389/fped.2024.1450710. eCollection 2024.
9
The changes of coagulation profiles in Kawasaki disease and its associations with clinical classification, intravenous immunoglobulin responsiveness and coronary artery involvement.川崎病凝血谱的变化及其与临床分类、静脉注射免疫球蛋白反应性和冠状动脉受累的关系。
Clin Exp Med. 2024 Aug 6;24(1):177. doi: 10.1007/s10238-024-01430-z.
10
Intravenous immunoglobulin resistance in Kawasaki disease patients: prediction using clinical data.川崎病患者静脉注射免疫球蛋白耐药:基于临床数据的预测。
Pediatr Res. 2024 Feb;95(3):692-697. doi: 10.1038/s41390-023-02519-z. Epub 2023 Feb 16.
川崎病的诊断、治疗和长期管理:美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
4
The current role and future prospects of D-dimer biomarker.D-二聚体生物标志物的当前作用和未来前景。
Eur Heart J Cardiovasc Pharmacother. 2016 Jul;2(3):175-84. doi: 10.1093/ehjcvp/pvv039. Epub 2015 Sep 27.
5
Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease.血清铁蛋白水平作为一种有用的诊断标志物,可用于区分全身型幼年特发性关节炎和川崎病。
Mod Rheumatol. 2016 Nov;26(6):929-932. doi: 10.3109/14397595.2016.1159120. Epub 2016 Jul 19.
6
Utility of ferritin as a predictor of the patients with Kawasaki disease refractory to intravenous immunoglobulin therapy.铁蛋白作为静脉注射免疫球蛋白治疗难治性川崎病患者预测指标的效用。
Mod Rheumatol. 2015;25(6):898-902. doi: 10.3109/14397595.2015.1038430. Epub 2015 May 27.
7
Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.D - 二聚体水平升高是静脉注射免疫球蛋白无反应性川崎病伴冠状动脉病变的一个危险因素。
Ther Apher Dial. 2015 Apr;19(2):171-7. doi: 10.1111/1744-9987.12235. Epub 2014 Sep 26.
8
Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease.血清白细胞介素-18作为鉴别全身型幼年特发性关节炎与不完全川崎病的潜在特异性标志物。
Rheumatol Int. 2015 Jan;35(1):81-4. doi: 10.1007/s00296-014-3059-2. Epub 2014 Jun 12.
9
Very high serum ferritin levels in three newborns with Kawasaki-like illness.三名患川崎病样疾病的新生儿血清铁蛋白水平极高。
Paediatr Child Health. 2012 Apr;17(4):201-4. doi: 10.1093/pch/17.4.201.
10
Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.川崎病患者静脉注射免疫球蛋白抵抗及冠状动脉病变与Th1/Th2细胞因子谱的关系评估
Arthritis Rheum. 2013 Mar;65(3):805-14. doi: 10.1002/art.37815.